Literature DB >> 8227004

Optimization of an anti-HIV hairpin ribozyme by in vitro selection.

S Joseph1, J M Burke.   

Abstract

We have applied in vitro selection methods to achieve a large increase in the catalytic activity of a hairpin ribozyme targeted against a highly conserved 14-nucleotide sequence within HIV-1 pol RNA. The substrate specificity was changed by mutating 8 bases within the substrate-binding domain of the parental (-)sTRSV ribozyme. The resulting enzyme cleaved the HIV substrate specifically but with a 20-fold reduction in catalytic efficiency (kcat/KM). Following random mutagenesis, ribozymes with increased activity against the target sequence were selected through 10 rounds of in vitro selection. Selective pressure was increased by decreasing MgCl2 and spermidine concentrations, and reducing reaction time. Variant ribozymes with base substitutions A11-->G and U39-->C were selected in the population. These mutations were introduced singly and in combination into the trans-acting anti-HIV ribozyme. Each of the single-base substitutions significantly increased ribozyme activity, while the activity of double mutant was increased to nearly the level of the parental ribozyme. These findings demonstrate that in vitro selection is a powerful and efficient method to optimize ribozymes for the catalytic inactivation of targeted RNA molecules.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8227004

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Structural diversity of self-cleaving ribozymes.

Authors:  J Tang; R R Breaker
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-23       Impact factor: 11.205

2.  Substrate specificity and reaction kinetics of an X-motif ribozyme.

Authors:  Denis Lazarev; Izabela Puskarz; Ronald R Breaker
Journal:  RNA       Date:  2003-06       Impact factor: 4.942

Review 3.  The RNA world on ice: a new scenario for the emergence of RNA information.

Authors:  Alexander V Vlassov; Sergei A Kazakov; Brian H Johnston; Laura F Landweber
Journal:  J Mol Evol       Date:  2005-07-13       Impact factor: 2.395

Review 4.  Inhibition of gene expression in human cells using RNase P-derived ribozymes and external guide sequences.

Authors:  Kihoon Kim; Fenyong Liu
Journal:  Biochim Biophys Acta       Date:  2007-09-29

5.  In vitro analysis of ribozyme-mediated knockdown of an ADRP associated rhodopsin mutation.

Authors:  Dibyendu Chakraborty; Patrick Whalen; Alfred S Lewin; Muna I Naash
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

Review 6.  Antigene, ribozyme and aptamer nucleic acid drugs: progress and prospects.

Authors:  R A Stull; F C Szoka
Journal:  Pharm Res       Date:  1995-04       Impact factor: 4.200

7.  Targeting nucleic acid secondary structures by antisense oligonucleotides designed through in vitro selection.

Authors:  R K Mishra; R Le Tinévez; J J Toulmé
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

8.  Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes.

Authors:  A M Diegelman; E T Kool
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

Review 9.  Antiviral ribozymes. New jobs for ancient molecules.

Authors:  A Menke; G Hobom
Journal:  Mol Biotechnol       Date:  1997-08       Impact factor: 2.695

10.  Generation of Ribozymes by Rolling Circle Transcription of Promoterless Single-Stranded DNA Circles in Mammalian Cells.

Authors:  Attila A Seyhan
Journal:  Turk Biyokim Derg       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.